MedTrace Logo

The Effectiveness of Pharmacist-led Educational Model in Patients With Allergic Rhinitis

NCT06027736 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 154

Last updated 2023-09-07

No results posted yet for this study

Summary

Allergic rhinitis is a chronic respiratory disorder affecting patients' quality of life and work performance. Pharmacists are identified as suitable professionals to deliver patient education and pharmaceutical care in managing allergic rhinitis (AR) patients. Local clinical practice guidelines in Malaysia are lacking, especially in pharmaceutical care in public healthcare institutions. This study protocol describes a randomised control trial (RCT) that aims to determine the effectiveness of a pharmacist-led educational model in managing AR (AR-PRISE Model) compared to standard pharmaceutical care. The AR-PRISE model delivers patient educational material (video) and an algorithm for pharmaceutical care.

Conditions

  • Allergic Rhinitis
  • Pharmaceutical Care
  • Pharmaceutical Services

Interventions

OTHER

pharmacist-led education

A patient education protocol and an algorithm of pharmaceutical care in managing allergic rhinitis.

Sponsors & Collaborators

  • Hospital Raja Permaisuri Bainun

    collaborator OTHER_GOV

  • Dr. Chee Ping Chong

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2024-06-30
Completion
2024-12-31

Countries

  • Malaysia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06027736 on ClinicalTrials.gov